시장보고서
상품코드
1377721

세계의 바이오리액터 시장(2024-2028년)

Global Bioreactors Market 2024-2028

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 161 Pages | 배송안내 : 즉시배송

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

개요

바이오리액터 시장은 2023년부터 2028년에 걸쳐 22억 3,130만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR) 6.99%로 성장할 것으로 예측됩니다.

바이오리액터 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 이 시장은 일회용 바이오리액터 수요 증가, 액세서리 제품의 가용성 증가, 이해관계자간 협력 관계 증가 등이 시장 성장을 가속하고 있습니다.

시장 범위
기준년 2024
종료년 2028
예측 기간 2024-2028
성장 모멘텀 가속
전년대비 2024년 6.1%
CAGR 6.99%
증분액 22억 3,130만 달러

신규 기업 부상과 기존 기업 지속적기술 진보가 향후 몇 년간 바이오리액터 시장 성장을 가속하는 주요인 중 하나라고 분석했습니다. 또한 부가가치 높은 소프트웨어 서비스 제공, 프로모션 지원 및 활동에 대한 요구 증가 또한 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 구도

  • 시장 생태계

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2023년)
  • 시장 전망(2023-2028년)

제4장 시장 규모 실적

  • 바이오리액터 세계 시장(2018-2022년)
  • 최종사용자별 부문 분석(2018-2022년)
  • 유형별 부문 분석(2018-2022년)
  • 지역별 부문 분석(2018-2022년)
  • 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 위협
  • 시장 현황

제6장 시장 세분화 : 최종사용자별

  • 시장 부문
  • 비교 : 최종사용자별
  • 바이오의약품 기업 : 시장 규모와 예측(2023-2028년)
  • 연구기관 : 시장 규모와 예측(2023-2028년)
  • CRO(의약품 임상시험수탁기관) : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 최종사용자별

제7장 시장 세분화 : 유형별

  • 시장 부문
  • 비교 : 유형별
  • 자동 : 시장 규모와 예측(2023-2028년)
  • 수동 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 유형별

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2023-2028년)
  • 유럽 : 시장 규모와 예측(2023-2028년)
  • 아시아 : 시장 규모와 예측(2023-2028년)
  • 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
  • 미국 : 시장 규모와 예측(2023-2028년)
  • 독일 : 시장 규모와 예측(2023-2028년)
  • 캐나다 : 시장 규모와 예측(2023-2028년)
  • 중국 : 시장 규모와 예측(2023-2028년)
  • 인도 : 시장 규모와 예측(2023-2028년)
  • 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 동향

제11장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란 상황
  • 업계 리스크

제12장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • 3D Biotek LLC
  • Automated Engineering Services Inc.
  • Bioengineering AG
  • Cell Culture Co. LLC
  • Danaher Corp.
  • Distek Inc.
  • Eppendorf SE
  • Getinge AB
  • Infors AG
  • LAMBDA CZ sro
  • Merck KGaA
  • PBS Biotech Inc.
  • Pierre Guerin SA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

제13장 부록

LSH 23.11.16

Abstract

The bioreactors market is forecasted to grow by USD 2231.3 mn during 2023-2028, accelerating at a CAGR of 6.99% during the forecast period. The report on the bioreactors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for single-use bioreactors, increased availability of accessory products, and increased collaborations among stakeholders.

Market Scope
Base Year2023
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.1%
CAGR6.99%
Incremental Value$2231.3mn

Technavio's bioreactors market is segmented as below:

By End-user

  • Biopharmaceutical companies
  • Research institutes
  • Contract research organizations

By Type

  • Automated
  • Manual

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of startups and continuous technological advances by existing players as one of the prime reasons driving the bioreactors market growth during the next few years. Also, availability of value-added software services and growing need for promotional support and activities will lead to sizable demand in the market.

The report on the bioreactors market covers the following areas:

  • Bioreactors market sizing
  • Bioreactors market forecast
  • Bioreactors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bioreactors market vendors that include Automated Engineering Services Inc., Bioengineering AG, BPC Instruments AB, Cell Culture Co. LLC, Danaher Corp., Distek Inc., Donaldson Co. Inc., Eppendorf SE, Getinge AB, Infors AG, LAMBDA CZ sro, Merck KGaA, PBS Biotech Inc., Pierre Guerin SA, Sartorius AG, Solida Biotech GmBH, Thermo Fisher Scientific Inc., Zellwerk GmbH, ZETA, and 3D Biotek LLC. Also, the bioreactors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global bioreactors market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global bioreactors market 2018 - 2022 ($ million)
  • 4.2 End-user Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.3 Type Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Biopharmaceutical companies - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • 6.4 Research institutes - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
  • 6.5 Contract research organizations - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
  • Exhibit 43: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
  • Exhibit 44: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by End-user
  • Exhibit 46: Market opportunity by End-user ($ million)
  • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 48: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
  • Exhibit 50: Chart on Comparison by Type
  • Exhibit 51: Data Table on Comparison by Type
  • 7.3 Automated - Market size and forecast 2023-2028
  • Exhibit 52: Chart on Automated - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on Automated - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on Automated - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on Automated - Year-over-year growth 2023-2028 (%)
  • 7.4 Manual - Market size and forecast 2023-2028
  • Exhibit 56: Chart on Manual - Market size and forecast 2023-2028 ($ million)
  • Exhibit 57: Data Table on Manual - Market size and forecast 2023-2028 ($ million)
  • Exhibit 58: Chart on Manual - Year-over-year growth 2023-2028 (%)
  • Exhibit 59: Data Table on Manual - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Type
  • Exhibit 60: Market opportunity by Type ($ million)
  • Exhibit 61: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Germany - Market size and forecast 2023-2028
  • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.9 Canada - Market size and forecast 2023-2028
  • Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
  • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 India - Market size and forecast 2023-2028
  • Exhibit 99: Chart on India - Market size and forecast 2023-2028 ($ million)
  • Exhibit 100: Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Exhibit 101: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on India - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 103: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 108: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 109: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
  • 12.3 3D Biotek LLC
  • Exhibit 111: 3D Biotek LLC - Overview
  • Exhibit 112: 3D Biotek LLC - Product / Service
  • Exhibit 113: 3D Biotek LLC - Key offerings
  • 12.4 Automated Engineering Services Inc.
  • Exhibit 114: Automated Engineering Services Inc. - Overview
  • Exhibit 115: Automated Engineering Services Inc. - Product / Service
  • Exhibit 116: Automated Engineering Services Inc. - Key offerings
  • 12.5 Bioengineering AG
  • Exhibit 117: Bioengineering AG - Overview
  • Exhibit 118: Bioengineering AG - Product / Service
  • Exhibit 119: Bioengineering AG - Key offerings
  • 12.6 Cell Culture Co. LLC
  • Exhibit 120: Cell Culture Co. LLC - Overview
  • Exhibit 121: Cell Culture Co. LLC - Product / Service
  • Exhibit 122: Cell Culture Co. LLC - Key offerings
  • 12.7 Danaher Corp.
  • Exhibit 123: Danaher Corp. - Overview
  • Exhibit 124: Danaher Corp. - Business segments
  • Exhibit 125: Danaher Corp. - Key news
  • Exhibit 126: Danaher Corp. - Key offerings
  • Exhibit 127: Danaher Corp. - Segment focus
  • 12.8 Distek Inc.
  • Exhibit 128: Distek Inc. - Overview
  • Exhibit 129: Distek Inc. - Product / Service
  • Exhibit 130: Distek Inc. - Key offerings
  • 12.9 Eppendorf SE
  • Exhibit 131: Eppendorf SE - Overview
  • Exhibit 132: Eppendorf SE - Product / Service
  • Exhibit 133: Eppendorf SE - Key news
  • Exhibit 134: Eppendorf SE - Key offerings
  • 12.10 Getinge AB
  • Exhibit 135: Getinge AB - Overview
  • Exhibit 136: Getinge AB - Business segments
  • Exhibit 137: Getinge AB - Key news
  • Exhibit 138: Getinge AB - Key offerings
  • Exhibit 139: Getinge AB - Segment focus
  • 12.11 Infors AG
  • Exhibit 140: Infors AG - Overview
  • Exhibit 141: Infors AG - Product / Service
  • Exhibit 142: Infors AG - Key offerings
  • 12.12 LAMBDA CZ sro
  • Exhibit 143: LAMBDA CZ sro - Overview
  • Exhibit 144: LAMBDA CZ sro - Product / Service
  • Exhibit 145: LAMBDA CZ sro - Key offerings
  • 12.13 Merck KGaA
  • Exhibit 146: Merck KGaA - Overview
  • Exhibit 147: Merck KGaA - Business segments
  • Exhibit 148: Merck KGaA - Key news
  • Exhibit 149: Merck KGaA - Key offerings
  • Exhibit 150: Merck KGaA - Segment focus
  • 12.14 PBS Biotech Inc.
  • Exhibit 151: PBS Biotech Inc. - Overview
  • Exhibit 152: PBS Biotech Inc. - Product / Service
  • Exhibit 153: PBS Biotech Inc. - Key offerings
  • 12.15 Pierre Guerin SA
  • Exhibit 154: Pierre Guerin SA - Overview
  • Exhibit 155: Pierre Guerin SA - Product / Service
  • Exhibit 156: Pierre Guerin SA - Key offerings
  • 12.16 Sartorius AG
  • Exhibit 157: Sartorius AG - Overview
  • Exhibit 158: Sartorius AG - Business segments
  • Exhibit 159: Sartorius AG - Key news
  • Exhibit 160: Sartorius AG - Key offerings
  • Exhibit 161: Sartorius AG - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 162: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 163: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 164: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 167: Inclusions checklist
  • Exhibit 168: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 169: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 170: Research methodology
  • Exhibit 171: Validation techniques employed for market sizing
  • Exhibit 172: Information sources
  • 13.5 List of abbreviations
  • Exhibit 173: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제